DALFAMPRIDINE
Generic: DALFAMPRIDINE
Aurobindo Pharma LimitedManufacturer
ORALRoute
DALFAMPRIDINEActive Substance
2017-01-23Original Approval
DALFAMPRIDINE is FDA application ANDA206811, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FALL
1,063 reports
2
GAIT DISTURBANCE
1,005 reports
3
DRUG INEFFECTIVE
836 reports
4
FATIGUE
813 reports
5
COVID-19
582 reports
6
MULTIPLE SCLEROSIS RELAPSE
574 reports
7
BALANCE DISORDER
551 reports
8
MULTIPLE SCLEROSIS
513 reports
9
ASTHENIA
438 reports
10
DIZZINESS
410 reports